Neko Health Expands to U.S. with $500 AI-Powered Body Scan

Neko Health, the Swedish healthtech startup co-founded by Spotify’s David Ek, has expanded to the U.S. with its first location in New York. The company offers a $500 AI-driven body scan aimed at preventative medicine, but scaling and regulatory hurdles could shape its future.

Tarun Mottlia

Editor, Lazyfounder

Published Oct 4, 20264 min read

Neko Health Expands to U.S. with $500 AI-Powered Body Scan — Image: Image Credits:Neko Health (opens in a new window) via source

30 SEC SUMMARY

Neko Health, co-founded by Spotify’s David Ek, has expanded to the U.S. with a New York launch, offering advanced body scans for preventative medicine.
The startup has raised nearly $1 billion and claims a global waitlist of over 300,000 people.
Neko Health’s $500 one-hour scan is not covered by insurance but may qualify for Health Savings Accounts.
The company uses AI and advanced computer vision to screen for issues in blood, skin, and metabolism.
Scaling and regulatory approval remain key challenges for Neko Health’s U.S. expansion.

Neko Health Launches in the U.S.
Funding and Technology
Challenges and Opportunities
What this means
Key takeaways
FAQ
Sources

KEY HIGHLIGHTS

Neko Health, co-founded by Spotify’s David Ek, has expanded to the U.S. with a launch in New York.
The startup has raised nearly $1 billion and claims a global waitlist of over 300,000 people.
Neko Health charges $500 for a one-hour scan, which may qualify for Health Savings Accounts but is not covered by insurance.
The company uses AI and advanced computer vision to screen for health issues in blood, skin, and metabolism.
Investor Farooq Abbasi praised Neko Health’s potential in preventative medicine but acknowledged scaling and regulatory challenges.

Neko Health Launches in the U.S.

Neko Health, a Swedish healthtech startup co-founded by Spotify billionaire David Ek and Hjalmar Nilsonne, has expanded to the U.S. with its first location in New York. The company specializes in advanced body scans designed to detect potential health issues in blood, skin, and metabolism, according to TechCrunch.

The startup has attracted significant attention, with a reported global waitlist exceeding 300,000 people. Neko Health’s scan, priced at $500 for a one-hour session, is not covered by insurance but may be eligible for reimbursement through Health Savings Accounts.

Funding and Technology

Neko Health has raised nearly $1 billion in funding, reflecting strong investor confidence in its approach to preventative medicine. The company uses AI and advanced computer vision technology to analyze health data, expanding its blood tests from 15 biomarkers to 55 biomarkers over time.

Farooq Abbasi, an investor at Preface Ventures, has publicly praised the company’s growth and potential. He described Neko Health as an example of how AI is transforming the medical sector, though he acknowledged the challenges of scaling and obtaining regulatory approval in the U.S.

Challenges and Opportunities

While Neko Health’s expansion into the U.S. signals optimism, the company faces hurdles in scaling its operations and navigating regulatory requirements. Preventative care adoption in the U.S. remains low, partly due to concerns about costs, which could impact demand for Neko Health’s services.

Abbasi, who has undergone the scan twice, expressed hope that venture capital will continue to support companies like Neko Health that are pushing boundaries in healthcare innovation.

What this means

Lazyfounder analysis — our interpretation, not reported fact.

Neko Health’s U.S. launch is a bold move for a startup focused on preventative medicine, an area where adoption has historically lagged. The nearly $1 billion in funding underscores investor enthusiasm for AI-driven healthtech, but the real test will be whether the company can scale effectively and secure regulatory approval. The $500 price point, while high, reflects the cost of cutting-edge technology, but it also limits accessibility—especially without insurance coverage. For founders, Neko Health’s journey is a case study in balancing ambition with practical challenges, particularly in a highly regulated industry like healthcare.

Key takeaways

Neko Health has launched in New York, marking its entry into the U.S. market.
The company’s $500 body scan is aimed at preventative medicine but is not covered by insurance.
Neko Health has raised nearly $1 billion and has a waitlist exceeding 300,000 people globally.
The startup uses AI-driven technology to screen for health issues in blood, skin, and metabolism.
Regulatory hurdles and scaling challenges could impact Neko Health’s expansion plans in the U.S.

FAQ

What does Neko Health’s body scan do?

Neko Health’s scan uses AI and advanced computer vision to screen for potential health issues in blood, skin, and metabolism. It analyzes 55 biomarkers, up from an initial 15.

How much does Neko Health’s scan cost?

The scan costs $500 for a one-hour session. It is not covered by insurance but may qualify for Health Savings Accounts.

Who founded Neko Health?

Neko Health was co-founded by David Ek, the billionaire co-founder of Spotify, and Hjalmar Nilsonne, a physician and entrepreneur.

What are the challenges Neko Health faces in the U.S.?

Neko Health must navigate regulatory approval and scaling its operations. Preventative care adoption in the U.S. is also relatively low, which could impact demand.

Related on Lazyfounder

Sources

TechCrunch · 2026-10-03
Spotify billionaire’s body scan startup has come to America

This story is an original summary drafted with AI by Lazyfounder from the reporting listed above and checked by automated validation. Facts are attributed to their original publishers; sections marked as analysis are Lazyfounder's. Where a source is in another language, facts were machine-translated and quotations are reported, not reproduced. Read the original coverage via the links, and see our AI policy and corrections policy.

About the author